Long-Term Outcomes of Multimodality Accelerated Partial Breast Irradiation for Ductal Carcinoma In Situ
APBI as a component of breast-conserving therapy for pure ductal carcinoma in situ is associated with excellent survival rates, local control, and cosmetic outcomes regardless of radiation therapy modality.
Authors
- Joanna Chensi Yang (ORCID: https://orcid.org/0000-0001-9106-7080)
- Alden D'Souza
- H.B. Stowe (ORCID: https://orcid.org/0000-0003-1331-5370)
- William R. Kennedy (ORCID: https://orcid.org/0000-0001-8583-1345)
- Jacqueline E. Zoberi (ORCID: https://orcid.org/0000-0003-1106-5224)
- Carmen Bergom (ORCID: https://orcid.org/0000-0002-0886-5055)
- Yi Huang (ORCID: https://orcid.org/0000-0002-2867-1477)
- S.C. Raju-Salicki (ORCID: https://orcid.org/0000-0003-2385-4415)
- Julie A. Margenthaler (ORCID: https://orcid.org/0000-0001-7028-4748)
- Randall Brenneman (ORCID: https://orcid.org/0000-0001-6167-1746)
- Imran Zoberi
- Katherine Glover‐Collins
- Maria A. Thomas
- Amy Cyr
- Mustafaa Mahmood
Institutions
- Charleston Area Medical Center (US)
- Washington University in St. Louis (US)
Publication Details
- Journal
- Advances in Radiation Oncology
- Published
- 2025-05-23
- DOI
- https://doi.org/10.1016/j.adro.2025.101792
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00